Canada Approves Generic Ozempic for Diabetes & Weight Loss

Canada Approves Generic Ozempic, Offering More Affordable Diabetes Treatment: A Canadian company, Apotex, has received approval for a generic version of semaglutide, the active ingredient in Ozempic, making it more affordable for Canadians with type 2 diabetes. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/7b5a38c66ea34dc5